Anne Schmidt
Plus aucun poste en cours
Profil
Anne Schmidt worked as an Associate Director-Integrated Early Development at ESBATech AG in 2013.
Prior to that, she was an Immunology Director at Apovia AG, a Senior Project Manager at Prionics AG, and a Junior Project Manager at Viramed Biotech AG.
Dr. Schmidt holds a doctorate degree from Universität Stuttgart.
Anciens postes connus de Anne Schmidt
| Sociétés | Poste | Fin |
|---|---|---|
Viramed Biotech AG
 Viramed Biotech AG Miscellaneous Commercial ServicesCommercial Services Viramed Biotech AG is a German company that specializes in infection serology and autoimmune diagnostics for human medicine. The private company was founded in 1983 and is based in Planegg, Germany. The company offers a range of products, including the Virachip® immunoblots, which can detect antibodies for various infections such as CMV, EBV, and SARS-CoV-2. The company also provides automation solutions for processing Virachip® tests, as well as IFt immunofluorescence tests and ELISA assays for parasite diagnostics. | Corporate Officer/Principal | - |
Prionics AG
 Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Corporate Officer/Principal | - |
| Apovia AG | Corporate Officer/Principal | - |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Corporate Officer/Principal | - |
Formation de Anne Schmidt
| Universität Stuttgart | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |
| Apovia AG | |
Viramed Biotech AG
Viramed Biotech AG Miscellaneous Commercial ServicesCommercial Services Viramed Biotech AG is a German company that specializes in infection serology and autoimmune diagnostics for human medicine. The private company was founded in 1983 and is based in Planegg, Germany. The company offers a range of products, including the Virachip® immunoblots, which can detect antibodies for various infections such as CMV, EBV, and SARS-CoV-2. The company also provides automation solutions for processing Virachip® tests, as well as IFt immunofluorescence tests and ELISA assays for parasite diagnostics. | Commercial Services |
